Design, Synthesis, and Characterization of Novel Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Potent Anti-Gram-Positive Activity-Reference-Cited by-同舟云学术

Design, Synthesis, and Characterization of Novel Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Potent Anti-Gram-Positive Activity

Published:2013-09-11 Issue:18 Volume:56 Page:7396-7415
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Surivet Jean-Philippe¹,Zumbrunn Cornelia¹,Rueedi Georg¹,Hubschwerlen Christian¹,Bur Daniel¹,Bruyère Thierry¹,Locher Hans¹,Ritz Daniel¹,Keck Wolfgang¹,Seiler Peter¹,Kohl Christopher¹,Gauvin Jean-Christophe¹,Mirre Azely¹,Kaegi Verena¹,Dos Santos Marina¹,Gaertner Mika¹,Delers Jonathan¹,Enderlin-Paput Michel¹,Boehme Maria¹

Affiliation:

1. Actelion Pharmaceuticals Ltd, Gewerbestrasse 16, CH-4123 Allschwil, Switzerland

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm400963y

Reference54 articles.

1. Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE

2. Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002

3. Clinical and Economic Outcomes Attributable to Health Care–Associated Sepsis and Pneumonia

4. Drugs for bad bugs: confronting the challenges of antibacterial discovery

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of Dibenzo[b,h][1,5]naphthyridin-7(12H)-ones: The Pictet–Spengler Reaction versus a Rearrangement of 4-Phenyl[1,3]oxazolo[4,5-c]quinolines;Synthesis;2024-05-10

2. Computational synthesis design for controlled degradation and revalorization;Nature Synthesis;2024-04-12

3. Dynamic Profiling and Binding Affinity Prediction of NBTI Antibacterials against DNA Gyrase Enzyme by Multidimensional Machine Learning and Molecular Dynamics Simulations;ACS Omega;2024-04-11

4. Gyrase and Topoisomerase IV: Recycling Old Targets for New Antibacterials to Combat Fluoroquinolone Resistance;ACS Infectious Diseases;2024-04-02

5. Interactions between Gepotidacin and Escherichia coli Gyrase and Topoisomerase IV: Genetic and Biochemical Evidence for Well-Balanced Dual-Targeting;ACS Infectious Diseases;2024-03-05